InvestorsHub Logo
Followers 43
Posts 5449
Boards Moderated 0
Alias Born 11/15/2013

Re: MackG post# 393397

Sunday, 09/18/2022 7:49:46 PM

Sunday, September 18, 2022 7:49:46 PM

Post# of 403121
Brilacidin is now in a nasal administered anti-viral going through dose strategy testing in-vivo.
This new development by George Mason University if successful could be an early treatment against influenza. Go B

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News